litlas
ログインアカウント作成

Jin Seok Ahn

1993–2025 年に発表

別表記
Jin‐Seok Ahn · Jin-Seok Ahn
167
論文数
20,053
被引用数
78
h 指数
158
i10 指数

被引用数

Jin Seok Ahn の年別被引用数1993 年: 被引用 1 件1995 年: 被引用 1 件1996 年: 被引用 1 件1997 年: 被引用 2 件1998 年: 被引用 1 件1999 年: 被引用 1 件2000 年: 被引用 3 件2001 年: 被引用 2 件2003 年: 被引用 1 件2004 年: 被引用 3 件2005 年: 被引用 1 件2006 年: 被引用 4 件2007 年: 被引用 3 件2008 年: 被引用 5 件2009 年: 被引用 13 件2010 年: 被引用 11 件2011 年: 被引用 29 件2012 年: 被引用 35 件2013 年: 被引用 76 件2014 年: 被引用 77 件2015 年: 被引用 89 件2016 年: 被引用 118 件2017 年: 被引用 133 件2018 年: 被引用 190 件2019 年: 被引用 611 件2020 年: 被引用 894 件2021 年: 被引用 1,015 件2022 年: 被引用 842 件2023 年: 被引用 707 件2024 年: 被引用 1,274 件2025 年: 被引用 680 件2026 年: 被引用 23 件1994 年は被引用が無いため表示していません2002 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,087 件、この内訳の 20%中国: 引用元論文 1,823 件、この内訳の 17.4%イタリア: 引用元論文 596 件、この内訳の 5.7%韓国: 引用元論文 531 件、この内訳の 5.1%イギリス: 引用元論文 470 件、この内訳の 4.5%日本: 引用元論文 466 件、この内訳の 4.5%フランス: 引用元論文 423 件、この内訳の 4%ドイツ: 引用元論文 398 件、この内訳の 3.8%スペイン: 引用元論文 358 件、この内訳の 3.4%カナダ: 引用元論文 305 件、この内訳の 2.9%スイス: 引用元論文 243 件、この内訳の 2.3%オランダ: 引用元論文 233 件、この内訳の 2.2%
0%20%その他 24.2%

機関

分野

  • Medicine73.6%
  • Biochemistry, Genetics and Molecular Biology18.2%
  • Immunology and Microbiology4.1%
  • Computer Science1.1%
  • Engineering1%
  • Chemistry0.4%
  • その他1.6%

トピック

  • Lung Cancer Treatments and Mutations13.6%
  • Cancer Immunotherapy and Biomarkers8.6%
  • Lung Cancer Research Studies7.9%
  • Cancer Genomics and Diagnostics4.9%
  • Lung Cancer Diagnosis and Treatment4.9%
  • Brain Metastases and Treatment2.2%
  • その他57.9%

共著者

全論文

検索で開く
  1. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma

    著者: Nayoung Kim, Hong Kwan Kim, Kyungjong Lee, Yourae Hong, Jong Ho Cho, Jung Won Choi, Jung-Il Lee, Yeon‐Lim Suh, Bo Mi Ku, Hye Hyeon Eum, Soyean Choi, Yoon‐La Choi, Je‐Gun Joung, Woong‐Yang Park, Hyun Ae Jung, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn, Hae‐Ock Lee - Nature Communications 2020 被引用: 1,337

  2. Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer

    著者: Solange Peters, D. Ross Camidge, Alice T. Shaw, Shirish M. Gadgeel, Jin Seok Ahn, Dong‐Wan Kim, Sai‐Hong Ignatius Ou, M. Pérol, Rafał Dziadziuszko, Rafael Rosell, Ali Zeaiter, Emmanuel Mitry, Sophie Golding, Bogdana Balas, Johannes Noé, Peter N. Morcos, Tony Mok - New England Journal of Medicine 2017 被引用: 2,455

  3. DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load

    著者: Hyunchul Jung, Hong Sook Kim, Jeong Yeon Kim, Jong‐Mu Sun, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park, Manel Esteller, Se‐Hoon Lee, Jung Kyoon Choi - Nature Communications 2019 被引用: 563

  4. Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study

    著者: Tony Mok, D. Ross Camidge, Shirish M. Gadgeel, Rafael Rosell, Rafał Dziadziuszko, D.-W. Kim, M. Pérol, S.-H.I. Ou, Jin Seok Ahn, A. Shaw, Walter Bordogna, Vlatka Smoljanović, Magalie Hilton, Thorsten Ruf, Johannes Noé, Solange Peters - Annals of Oncology 2020 被引用: 686

  5. Artificial Intelligence–Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non–Small-Cell Lung Cancer

    著者: Sehhoon Park, Chan‐Young Ock, Hyojin Kim, Sérgio Pereira, Seonwook Park, Minuk Ma, Sangjoon Choi, Seokhwi Kim, Seunghwan Shin, Brian Jaehong Aum, Kyunghyun Paeng, Donggeun Yoo, Hongui Cha, Sunyoung Park, Koung Jin Suh, Hyun Ae Jung, Se Hyun Kim, Yu Jung Kim, Jong‐Mu Sun, Jin-Haeng Chung, Jin Seok Ahn, Myung‐Ju Ahn, Jong Seok Lee, Keunchil Park, Sang Yong Song, Yung‐Jue Bang, Yoon‐La Choi, Tony Mok, Se‐Hoon Lee - Journal of Clinical Oncology 2022 被引用: 282

  6. Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer

    著者: Yi‐Long Wu, Rafał Dziadziuszko, Jin Seok Ahn, Fabrice Barlési, Makoto Nishio, Ki Hyeong Lee, Jong Seok Lee, Wen‐Zhao Zhong, Hidehito Horinouchi, Weimin Mao, Maximilian J. Hochmair, Filippo de Marinis, M.R. Migliorino, Igor Bondarenko, Shun Lü, Qun Wang, Tania Ochi Lohmann, Tingting Xu, Andrés F. Cardona, Thorsten Ruf, Johannes Noé, Benjamin Solomon - New England Journal of Medicine 2024 被引用: 382

  7. Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Rearranged or Translocated Non–Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)

    著者: Sehhoon Park, Tae Min Kim, Ji‐Youn Han, Gyeong‐Won Lee, Byoung Yong Shim, Yun‐Gyoo Lee, Sang‐We Kim, Il Hwan Kim, Suee Lee, Yu Jung Kim, Ji Hyun Park, Sang-Gon Park, Ki Hyeong Lee, Eun Joo Kang, Ju Won Kim, Seong Hoon Shin, Chan‐Young Ock, Byung‐Ho Nam, Jaebong Lee, Hyun Ae Jung, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Myung‐Ju Ahn - Journal of Clinical Oncology 2023 被引用: 164

  8. Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study

    著者: James Chih‐Hsin Yang, Sang-We Kim, Dong‐Wan Kim, Jong Seok Lee, Byoung Chul Cho, Jin-Seok Ahn, Dae H. Lee, Tae Min Kim, Jonathan W. Goldman, Ronald B. Natale, Andy Brown, Barbara Collins, Juliann Chmielecki, Karthick Vishwanathan, Ariadna Mendoza‐Naranjo, Myung‐Ju Ahn - Journal of Clinical Oncology 2019 被引用: 397

  9. LBA2 ALINA: Efficacy and safety of adjuvant alectinib versus chemotherapy in patients with early-stage ALK+ non-small cell lung cancer (NSCLC)

    著者: Benjamin Solomon, Jin Seok Ahn, Rafał Dziadziuszko, Fabrice Barlési, Makoto Nishio, Daniel Lee, Jin Sun Lee, W-Z. Zhong, Hidehito Horinouchi, Weimin Mao, Maximilian J. Hochmair, Filippo de Marinis, M.R. Migliorino, Igor Bondarenko, Tania Ochi Lohmann, Tao Xu, A. Cardona Gavaldon, Walter Bordogna, Thorsten Ruf, Yi‐Long Wu - Annals of Oncology 2023 被引用: 71

  10. The First-week Proliferative Response of Peripheral Blood PD-1+CD8+ T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors

    著者: Kyung Hwan Kim, Jinhyun Cho, Bo Mi Ku, Jiae Koh, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Jaekyung Cheon, Young Joo Min, Su‐Hyung Park, Keunchil Park, Myung‐Ju Ahn, Eui‐Cheol Shin - Clinical Cancer Research 2019 被引用: 212

  11. Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)

    著者: Jang Ho Cho, Sung Hee Lim, Ho Jung An, Ki Hwan Kim, Keon Uk Park, Eun Joo Kang, Yoon Hee Choi, Mi Sun Ahn, Myung Hee Lee, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn - Journal of Clinical Oncology 2019 被引用: 359

  12. BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non–Small Cell Lung Cancer

    著者: Sun Min Lim, Toshio Fujino, Chulwon Kim, Gwanghee Lee, Yong-Hee Lee, Dong‐Wan Kim, Jin Seok Ahn, Tetsuya Mitsudomi, Taiguang Jin, Sang-Yoon Lee - Clinical Cancer Research 2023 被引用: 72

  13. A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy

    著者: Seo‐Young Park, M.-H. Lee, Minjung Seong, S.T. Kim, Jin Hyoung Kang, Byoung Chul Cho, K.H. Lee, E.K. Cho, Jong‐Mu Sun, S.-H. Lee, Jin Seok Ahn, K. Park, Myung‐Ju Ahn - Annals of Oncology 2020 被引用: 192

  14. Regulatory (FoxP3+) T cells and TGF-β predict the response to anti-PD-1 immunotherapy in patients with non-small cell lung cancer

    著者: Jiae Koh, Joon Young Hur, Kyoung Young Lee, Mi Soon Kim, Jae Yeong Heo, Bo Mi Ku, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn - Scientific Reports 2020 被引用: 87

  15. HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients

    著者: Joonho Shim, H.S. Kim, Hongui Cha, Soo‐Chan Kim, T.M. Kim, Valsamo Anagnostou, Yoon‐La Choi, Hyun Ae Jung, Jong‐Mu Sun, Jin Seok Ahn, Myung‐Ju Ahn, K. Park, W.-Y. Park, S.-H. Lee - Annals of Oncology 2020 被引用: 149

  16. Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial

    著者: Jinhyun Cho, Hae Su Kim, Bo Mi Ku, Yoon‐La Choi, Răzvan Cristescu, Joungho Han, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn - Journal of Clinical Oncology 2018 被引用: 343

  17. Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures

    著者: Zhengyan Kan, Ying Ding, Jin-Ho Kim, Hae Hyun Jung, Woosung Chung, Samir Lal, Soonweng Cho, Julio Fernandez-Banet, Se Kyung Lee, Seok Won Kim, Jeong Eon Lee, Yoon‐La Choi, Shibing Deng, Ji‐Yeon Kim, Jin Seok Ahn, Ying Sha, Xinmeng Jasmine Mu, Jae‐Yong Nam, Young‐Hyuck Im, Soo Hyun Lee, Woong‐Yang Park, Seok Jin Nam, Yeon Hee Park - Nature Communications 2018 被引用: 210

  18. Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study

    著者: Myung‐Ju Ahn, Ji‐Youn Han, Ki Hyeong Lee, Sang-We Kim, Dong‐Wan Kim, Yun‐Gyoo Lee, Eun Kyung Cho, Joo-Hang Kim, Gyeong‐Won Lee, Jong Seok Lee, Young Joo Min, Jin-Soo Kim, Sung Sook Lee, Hye Ryun Kim, Min Hee Hong, Jin Seok Ahn, Jong‐Mu Sun, Heung Tae Kim, Ki Hyeong Lee, Sohee Kim, Byoung Chul Cho - The Lancet Oncology 2019 被引用: 135

  19. A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors

    著者: Byoung Chul Cho, Ji‐Youn Han, Sang‐We Kim, Ki Hyeong Lee, Eun Kyung Cho, Yun‐Gyoo Lee, Dong‐Wan Kim, Joo-Hang Kim, Gyeong‐Won Lee, Jong-Seok Lee, Byoung Yong Shim, Jin-Soo Kim, Sang Hoon Chun, Sung Sook Lee, Hye Ryun Kim, Min Hee Hong, Jin Seok Ahn, Jong‐Mu Sun, Youngjoo Lee, Ki Hyeong Lee, Ji Ah Kang, NaMi Lee, Mijung Kwon, Carin R. Espenschied, Arielle Yablonovitch, Myung‐Ju Ahn - Journal of Thoracic Oncology 2021 被引用: 91

  20. Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stages I to IIIA EGFR-Mutant Non–Small Cell Lung Cancer

    著者: Hyun Ae Jung, Bo Mi Ku, Yeon Jeong Kim, Sehhoon Park, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Jong Ho Cho, Hong Kwan Kim, Yong Soo Choi, Yoon‐La Choi, Sun Hye Shin, Byeong‐Ho Jeong, Sang‐Won Um, Hojoong Kim, Kyunga Kim, Myung‐Ju Ahn, Jingook Kim - Journal of Thoracic Oncology 2023 被引用: 67

  21. Prevalence and detection of low-allele-fraction variants in clinical cancer samples

    著者: Hyun‐Tae Shin, Yoon‐La Choi, Jae Won Yun, Nayoung K. D. Kim, Sook‐Young Kim, Hyo Jeong Jeon, Jae‐Yong Nam, Chung Lee, Daeun Ryu, Sang Cheol Kim, Kyunghee Park, Eunjin Lee, Joon Seol Bae, Dae Soon Son, Je‐Gun Joung, Jeeyun Lee, Seung Tae Kim, Myung‐Ju Ahn, Se‐Hoon Lee, Jin Seok Ahn, Woo Yong Lee, Bo Young Oh, Yeon Hee Park, Jeong Eon Lee, Kwang Hyuk Lee, Hee Cheol Kim, Kyoung‐Mee Kim, Young‐Hyuck Im, Keunchil Park, Peter J. Park, Woong‐Yang Park - Nature Communications 2017 被引用: 198

  22. Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015

    著者: Da Som Jeon, Ho Cheol Kim, Se Hee Kim, Tae Jung Kim, Hong Kwan Kim, Mi Hyung Moon, Kyongmin Sarah Beck, Yang-Gun Suh, Changhoon Song, Jin Seok Ahn, Jeong Eun Lee, Jeong Uk Lim, Jae Hyun Jeon, Kyu‐Won Jung, Chi Young Jung, Jeong Su Cho, Yoo Duk Choi, Seung-Sik Hwang, Chang‐Min Choi, Korea Central Cancer Registry - Cancer Research and Treatment 2022 被引用: 99

  23. MDSC subtypes and CD39 expression on CD8 + T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC

    著者: Jiae Koh, Youjin Kim, Kyoung Young Lee, Joon Young Hur, Mi Soon Kim, Boram Kim, Hee Jin Cho, Yeong Chan Lee, Yeon Hee Bae, Bo Mi Ku, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn - European Journal of Immunology 2020 被引用: 90

  24. Development and Validation of Digital Health Technology Literacy Assessment Questionnaire

    著者: Junghee Yoon, Mangyeong Lee, Jin Seok Ahn, Dongryul Oh, Soo-Yong Shin, Yoon Jung Chang, Juhee Cho - Journal of Medical Systems, J. Medical Syst. 2022 被引用: 69